Comparative In Vitro Toxicology of Novel Cytoprotective Short-Chain Naphthoquinones.

cytotoxicity idebenone mitochondria short-chain quinone

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
07 Aug 2020
Historique:
received: 30 07 2020
accepted: 05 08 2020
entrez: 14 8 2020
pubmed: 14 8 2020
medline: 14 8 2020
Statut: epublish

Résumé

Short-chain quinones (SCQs) have been identified as potential drug candidates against mitochondrial dysfunction, which largely depends on the reversible redox characteristics of the active quinone core. We recently identified 11 naphthoquinone derivatives,

Identifiants

pubmed: 32784558
pii: ph13080184
doi: 10.3390/ph13080184
pmc: PMC7463972
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Foundation for Medical Research and Innovation
ID : N/A

Références

Medchemcomm. 2019 Jan 16;10(3):399-412
pubmed: 30996858
PLoS One. 2011 Mar 23;6(3):e18021
pubmed: 21448285
Oxid Med Cell Longev. 2019 Jun 16;2019:7210892
pubmed: 31316720
Expert Opin Drug Metab Toxicol. 2010 Nov;6(11):1437-44
pubmed: 20955109
Arch Gerontol Geriatr. 1992 Nov-Dec;15(3):225-37
pubmed: 15374362
Environ Mol Mutagen. 1998;31(4):327-32
pubmed: 9654241
Biochem Biophys Res Commun. 2017 Nov 4;493(1):207-212
pubmed: 28899781
J Biol Chem. 2011 Sep 9;286(36):31361-72
pubmed: 21708945
Clin Pharmacol Ther. 2019 Jan;105(1):101-111
pubmed: 30058726
Arch Gynecol Obstet. 2016 Oct;294(4):797-804
pubmed: 27091196
Cell Death Differ. 2009 Jan;16(1):3-11
pubmed: 18846107
Biol Pharm Bull. 2018 May 1;41(5):722-732
pubmed: 29445054
Biomaterials. 2017 Jun;129:163-175
pubmed: 28343003
J Biochem. 2020 Feb 1;167(2):151-163
pubmed: 31599960
Mol Genet Metab. 2002 Sep-Oct;77(1-2):21-30
pubmed: 12359126
J Agric Food Chem. 2019 Jul 24;67(29):8243-8252
pubmed: 31271289
PLoS One. 2012;7(9):e45182
pubmed: 23028832
Eur J Clin Pharmacol. 1996;51(2):167-9
pubmed: 8911883
Mitochondrion. 2016 Sep;30:105-16
pubmed: 27423788
Sci Rep. 2017 Sep 7;7(1):10841
pubmed: 28883490
Mol Cell Neurosci. 2020 Jan;102:103419
pubmed: 31770591
PLoS One. 2011 Mar 31;6(3):e17963
pubmed: 21483849
J Neuroophthalmol. 2013 Mar;33(1):30-6
pubmed: 23263355
Biofactors. 2008;34(3):183-90
pubmed: 19734119
PLoS One. 2012;7(4):e36153
pubmed: 22558363
Pediatr Pulmonol. 2017 Apr;52(4):508-515
pubmed: 27571420
Lancet Neurol. 2007 Oct;6(10):878-86
pubmed: 17826341
Naunyn Schmiedebergs Arch Pharmacol. 2014 Sep;387(9):799-809
pubmed: 24879465
Brain. 2011 Sep;134(Pt 9):2677-86
pubmed: 21788663
Environ Toxicol Pharmacol. 2017 Oct;55:1-7
pubmed: 28787644
J Biomol Screen. 2007 Oct;12(7):938-45
pubmed: 17942786
Hum Mol Genet. 2019 Feb 1;28(3):422-433
pubmed: 30304398
Brain. 2013 Feb;136(Pt 2):e231
pubmed: 23388408
Biochemistry (Mosc). 2018 Jul;83(7):813-830
pubmed: 30200866
Oncotarget. 2018 Jan 30;9(15):12137-12153
pubmed: 29552298
Orphanet J Rare Dis. 2017 Oct 16;12(1):163
pubmed: 29037240
Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):284-291
pubmed: 27815040
Brain. 2013 Feb;136(Pt 2):e230
pubmed: 23388409
Pharmaceuticals (Basel). 2020 Feb 12;13(2):
pubmed: 32059451
Pharmacol Res. 2018 Nov;137:89-103
pubmed: 30290222
Hepatology. 1993 Jun;17(6):1163-4
pubmed: 8514267
Redox Biol. 2015;4:289-95
pubmed: 25625583
Am Heart J. 2011 Mar;161(3):639-645.e1
pubmed: 21392622
Dis Model Mech. 2018 Aug 31;11(9):
pubmed: 30171034
Ann Clin Transl Neurol. 2020 Apr;7(4):590-594
pubmed: 32243103
Free Radic Biol Med. 2010 Feb 1;48(3):421-9
pubmed: 19932748
J Pharmacobiodyn. 1985 Jun;8(6):457-67
pubmed: 4057041
J Diabetes Complications. 2017 Jan;31(1):253-259
pubmed: 27422531
Mol Genet Metab. 2012 Nov;107(3):383-8
pubmed: 23010433
Eur J Clin Pharmacol. 2009 May;65(5):493-501
pubmed: 19125241

Auteurs

Zikai Feng (Z)

School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.
School of Natural Sciences, University of Tasmania, Hobart, TAS 7005, Australia.

Mohammed Sedeeq (M)

School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.

Abraham Daniel (A)

School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.

Monika Corban (M)

School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.

Krystel L Woolley (KL)

School of Natural Sciences, University of Tasmania, Hobart, TAS 7005, Australia.

Ryan Condie (R)

School of Natural Sciences, University of Tasmania, Hobart, TAS 7005, Australia.

Iman Azimi (I)

School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.

Jason A Smith (JA)

School of Natural Sciences, University of Tasmania, Hobart, TAS 7005, Australia.

Nuri Gueven (N)

School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.

Classifications MeSH